Delivery Order SPE2DB22D2211-SPE2DB25FSCQQ
- Not listed
- The Defense Logistics Agency awarded a $30,970.59 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Kineret 100 mg/0.67 ml syringes. This non-set-aside, firm fixed price delivery order is scheduled for completion by August 8, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Kineret (anakinra) is a recombinant interleukin-1 receptor antagonist used primarily for treating rheumatoid arthritis and...
- The Defense Logistics Agency (DLA) awarded a $10,742.64 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Kineret 100 mg/0.67 mL syringes. Kineret (anakinra) is a recombinant interleukin-1 receptor antagonist used to treat rheumatoid arthritis and other inflammatory conditions. The contract represents a firm fixed-price delivery order with an ultimate completion date of October 8, 2025, and will be performed at the company's location in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Kineret 100 mg/0.67 mL syringes. The contract is valued at $3,580.88 with a firm fixed price structure and an ultimate completion date of September 19, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Kineret 100 mg/0.67 ml syringes on June 20, 2025, with a ceiling value of $3,580.88 and an ultimate completion date of July 14, 2025. This competitively awarded, non-set-aside delivery order employs firm fixed price pricing and is executed from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing...
- The Defense Logistics Agency awarded a $3,580.88 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Kineret 100 mg/0.67 mL syringes. This non-set-aside contract is scheduled for completion by September 9, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, will fulfill this delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,790.44 to AmerisourceBergen Drug Corp for the supply of Kineret 100 mg/0.67 mL syringes. This competitive, non-set-aside contract utilizes firm fixed pricing and specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania location, with an ultimate completion date of May 30, 2025. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $2,685.66 to AmerisourceBergen Drug Corp for the supply of Kineret 100 mg/0.67 ml syringes. The contract was competitively awarded without a set-aside designation and carries a firm fixed price structure. Performance will be completed by August 28, 2025, with the contract issued on August 7, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery...
- The Defense Logistics Agency awarded a $3,580.88 delivery order to AmerisourceBergen Drug Corp for the supply of Kineret (anakinra) 100 mg/0.67 mL syringes on May 28, 2025, with completion scheduled for June 18, 2025. This firm fixed-price delivery order was competitively awarded without any set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Kineret is a recombinant human interleukin-1 receptor antagonist used to treat rheumatoid...
- The Defense Logistics Agency awarded a $4,476.10 delivery order to AmerisourceBergen Drug Corp for Kineret 100 mg/0.67 mL syringes on June 5, 2025, with an ultimate completion date of June 27, 2025. This firm fixed-price contract, which is non-set-aside and competitively awarded, represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $3,580.88 to AmerisourceBergen Drug Corp for Kineret 100 mg/0.67 mL syringes on September 9, 2025, with completion targeted for September 30, 2025. This firm fixed-price, non-set-aside contract will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement needs...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSCQQDelivery Order
The Defense Logistics Agency (DLA) awarded a $7,161.76 delivery order to AmerisourceBergen Drug Corp for Kineret 100 mg/0.67 mL syringes on August 11, 2025, with an ultimate completion date of September 2, 2025. This firm fixed price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Kineret is a biopharmaceutical product used to treat rheumatoid arthritis and other inflammatory conditions, addressing critical medical supply needs within the federal healthcare system. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a key vendor for federal medical procurement through its comprehensive IDC with DLA. The parent IDC functions as a global pharmaceutical support vehicle enabling the company to supply a vast range of medications, vaccines, syringes, and medical supplies to support military healthcare programs and other federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. This specific delivery order reflects the company's ongoing capability to fulfill federal pharmaceutical requirements through competitive, open-market contracting without set-aside designations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 8/11/25 |